Agoracom: Small Cap Investment - Mosaic ImmunoEngineering Inc. - Re: Why not "stabalize" at .53 or .62?

Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Reply New Message

Prev Message Back To Forum Threaded View Next Message

eastcoast

Rank: Treasurer [?]

Points: 826 [?]

Votes: 42 Score: 2.7 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Why not "stabalize" at .53 or .62? - eastcoast

in response to

Re: Why not "stabalize" at .53 or .62? - eastcoast

SGE1

posted on May 29, 2007 10:02AM

Thanks for the help. To many agreements to follow.

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply